MAPT and tauopathy: These include genetic and autopsy data from human tauopathies, as well as nonclinical models of disease, such as induced pluripotent stem cell models and transgenic rodents that express mutant forms of tau associated with autosomal dominant frontotemporal dementia (FTD) (10, 11).